Ample evidence supports the overexpression/increase of human KLK6 in both ovarian tumours and presurgical serum of patients with ovarian cancer (Hoffman et al, 2002; Diamandis et al, 2003; Yousef et al, 2003a). Here, KLK6 is linked to ovarian carcinoma.